The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health•

Category: Oncology

Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors
Biotics and Supplements

Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors

NOV 6, 2023
Scientists and clinicians use AI analysis of the gut microbiome to detect colon cancer
Gastrointestinal

Scientists and clinicians use AI analysis of the gut microbiome to detect colon cancer

JUN 12, 2023
SNIPR Biome’s data on drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
Finance

SNIPR Biome’s data on drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology

MAY 8, 2023
FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013
Clinical & Manufacturing

FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013

APR 28, 2023
Engineered bacteria find tumors, then alert the authorities
GMO & Synbio

Engineered bacteria find tumors, then alert the authorities

MAR 13, 2023
Colorectal cancer surgery: Gut microbiota helps healing
Gastrointestinal

Colorectal cancer surgery: Gut microbiota helps healing

MAR 8, 2023
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform
Finance

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

FEB 10, 2023
MD Anderson and Federation Bio to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers
Oncology

MD Anderson and Federation Bio to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers

FEB 2, 2023
Micronoma receives FDA breakthrough device designation for novel liquid biopsy assay for lung carcinoma detection
Oncology

Micronoma receives FDA breakthrough device designation for novel liquid biopsy assay for lung carcinoma detection

JAN 12, 2023
Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment
Oncology

Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment

OCT 14, 2022
First-ever mycobiome atlas describes associations between cancers and fungi
Oncology

First-ever mycobiome atlas describes associations between cancers and fungi

OCT 3, 2022